News and commentary from the psychiatry world ...

The FDA just got sued by major health groups over a policy letting vapes and nicotine pouches stay on shelves without real ...

Would you want two strangers in the room with you for hours while you're on mushrooms? The federal government just decided ...

The drug from Merck was OK'd for patients with artery-clogging cholesterol that persists even after taking statins.

FDA finalized new guidance for testing MDMA and psilocybin in trials, days after Massachusetts advanced its own psychedelic ...

Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.

The FDA is holding a public hearing to talk through psychedelic drug development on 14 September.

HHS Secretary RFK Jr. is announcing updated FDA standards for pasteurized orange juice. Here is what the 10% Brix shift means ...

The U.S. Sentencing Guidelines play a pivotal role in some of the federal government's most consequential drug policy ...

The FDA approved Lipfendra, a new drug for adults with high LDL cholesterol, as the first PCSK9 inhibitor available as a once ...

Most adults have levels of a dangerous type of cholesterol that are above 100, but this new drug can reduce levels to around ...

A coalition of public health organizations, pediatricians and parents sued the U.S. Food and Drug Administration on Tuesday, ...